基本信息
浏览量:254
职业迁徙
个人简介
His primary research interests are in the areas of cancer biology and molecular therapeutics. Prof. Gallagher originally graduated from the Department of Biochemistry, UCD in 1993 with a 1st Class Joint Honours degree in Molecular Genetics and Biochemistry. Subsequently, he obtained a PhD in Molecular and Cellular Biology from the Cancer Research UK Beatson Laboratories in Glasgow. In 1997, he moved to Paris to undertake a Marie Curie Individual Fellowship at Rhone-Poulenc Rorer (currently Sanofi-Aventis). Afterwards, he returned to Ireland upon receipt of an Enterprise Ireland Post-Doctoral Fellowship (1999-2000) and, subsequently, a Marie Curie Return Fellowship (2000-2001). In 2001, he was employed in a permanent capacity as College Lecturer at UCD within the former Department of Pharmacology. In 2005, he was appointed Senior Lecturer within the UCD School of Biomolecular and Biomedical Science and was promoted to Associate Professor of Cancer Biology in 2006. In September 2009, Prof. Gallagher took up the position of Vice-Principal of Research and Innovation at the UCD College of Life Sciences, and was appointed a Conway Fellow at the UCD Conway Institute. In 2007, he co-founded OncoMark Ltd. (where he is currently Chief Scientific Officer), which is a private company centred on the development and application of biomarker panels and associated technologies, on both tissues and biological fluids (www.oncomark.com). A major focus of Prof. Gallagher's research work is the identification and validation of candidate biomarkers of breast cancer and melanoma, with particular emphasis on translation of transcriptomic and proteomic datasets into clinically relevant assays. In addition, his team utilises lentiviral-based approaches to investigate the functional relevance of candidate tumour progression-associated genes at both in vitro and in vivo levels, as well as engages in preclinical evaluation of novel anti-cancer agents. Prof. Gallagher has a track record of success in attracting European funding and has participated as a co-ordinator/partner in several EU framework programmes. He previously co-ordinated 3 Industry-Academia Partnership (& Pathways) Programmes in breast cancer (Target-Breast), melanoma (Target-Melanoma), and prostate cancer (FAST-PATH). He currently co-ordinates the FP7 programmes, SYS-MEL, which uses systems medicine approaches to develop new diagnostic solutions in melanoma (www.sysmel.com), and RATHER, which focuses on new rationalised therapy options for difficult-to-treat breast cancer (www.rather.com). Since 1999, he has attracted more than 65 million euro in research funding from both national and external sources, over 28 million euro of this as a principal applicant. Together with Prof. John Crown, Prof. Gallagher was also co-PI on a major Science Foundation Ireland-funded Strategic Research Cluster, Molecular Therapeutics of Cancer Ireland, which ran from 2009 to 2014 (www.mtci.ie). This was one of the most extensive organ-independent programmes in translational cancer research within Ireland, involving extensive collaboration with pharmaceutical, biotech and imaging companies. Prof. Gallagher has received a number of awards based on his research work to date, including the BACR/AstraZeneca Young Scientist Frank Rose Award in 2004, the St. Luke's Silver Medal Award in 2008, and the RAMI Doctors award in Oncology in 2013. Prof. Gallagher has had productive collaborative interactions with a variety of other industrial partners throughout his research, and has filed multiple patents. Research Links: Research in SBBS | Mechanisms of Disease (Cancer) Research in SBBS | Model Organisms Research in SBBS | Cancer Biology & Therapeutics Lab | BREAST-PREDICT | Oncomark Limited
研究兴趣
论文共 534 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
CANCER RESEARCHno. 5 (2024)
Zak Kinsella, Hannah Nyarko,Anna Blümel,Mairi Lucas, Daria Kalinska-Lysiak,Claudia Aura Gonzalez,Arman Rahman,Joanna Fay, Tony O'Grady, Verena Murphy,John Crown, Cathy Kelly,
Cancer Researchno. 9_Supplement (2024): PS16-10
William M Gallagher, Christine McCaffrey, Chowdhury Jahangir, Clodagh Murphy, Caoimbhe Burke,Arman Rahman
Binbin Gao,Elspeth Ward,Anna Blümel,Emer Conroy, Rachel Moore, Grainne Cremin,Rachel Bleach, Kathryn Haley,Tríona Ní Chonghaíle, Andreas Lindner,Jochen Prehn,Yi Zhang,
Cancer Researchno. 9_Supplement (2024): PO3-18
Marc Walsh, Asia Jordan, Lea Schäfer, Jana Joha, Ben Heapes, Megan Noonan,William Gallagher, Hubert Gallagher,Rustom P. Manecksha,David Galvin, Greg Nason, Terri Martin,
Clinical Genitourinary Cancerpp.102063, (2024)
Rachel Moore,Anna Blümel, Elspeth Ward,Elizabeth Sainsbury,Emer Conroy, Fergal O’Brien,Caroline Curtin,Simak Ali, Helen McCarthy,William Gallagher, Darran O'Connor
Cancer Researchno. 9_Supplement (2024): PO2-24
Mark Lawler,Richard Sullivan,Ghassan K. Abou-Alfa,Karen McCloskey, Debbie Keatley, Jennifer Feighan, William Dahut,Eibhlin Mulroe,Robert Ladner, Mohamed Genead,Maeve Lowery,James L. Gulley,
JOURNAL OF CANCER POLICY (2023): 100448-100448
crossref(2023)
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn